X-48805635-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4BS2
The NM_006044.4(HDAC6):c.401G>A(p.Arg134Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000107 in 1,179,817 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 39 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.00011 ( 0 hom. 37 hem. )
Consequence
HDAC6
NM_006044.4 missense
NM_006044.4 missense
Scores
1
8
8
Clinical Significance
Conservation
PhyloP100: 3.62
Genes affected
HDAC6 (HGNC:14064): (histone deacetylase 6) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), HDAC6. . Gene score misZ 3.2915 (greater than the threshold 3.09). GenCC has associacion of gene with X-linked dominant chondrodysplasia, Chassaing-Lacombe type.
BP4
Computational evidence support a benign effect (MetaRNN=0.40240854).
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HDAC6 | NM_006044.4 | c.401G>A | p.Arg134Gln | missense_variant | 6/29 | ENST00000334136.11 | NP_006035.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 111913Hom.: 0 Cov.: 23 AF XY: 0.0000587 AC XY: 2AN XY: 34085
GnomAD3 genomes
AF:
AC:
12
AN:
111913
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34085
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000525 AC: 7AN: 133413Hom.: 0 AF XY: 0.000118 AC XY: 5AN XY: 42351
GnomAD3 exomes
AF:
AC:
7
AN:
133413
Hom.:
AF XY:
AC XY:
5
AN XY:
42351
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000107 AC: 114AN: 1067904Hom.: 0 Cov.: 29 AF XY: 0.000107 AC XY: 37AN XY: 346648
GnomAD4 exome
AF:
AC:
114
AN:
1067904
Hom.:
Cov.:
29
AF XY:
AC XY:
37
AN XY:
346648
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000107 AC: 12AN: 111913Hom.: 0 Cov.: 23 AF XY: 0.0000587 AC XY: 2AN XY: 34085
GnomAD4 genome
AF:
AC:
12
AN:
111913
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34085
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.401G>A (p.R134Q) alteration is located in exon 6 (coding exon 5) of the HDAC6 gene. This alteration results from a G to A substitution at nucleotide position 401, causing the arginine (R) at amino acid position 134 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
.;D;D;D;.;D;D;.;.;D;D;.;.;.;D;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;.;.;.;.;.;.;.;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;.;M;.;M;M;.;.;M;M;.;.;.;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;.;D;D;.;.;.;.;D;.;.;D;D
REVEL
Uncertain
Sift
Benign
T;D;D;D;.;D;D;.;.;.;.;D;.;.;D;D
Sift4G
Benign
T;T;T;T;.;T;T;.;.;.;.;T;.;.;T;T
Polyphen
0.97, 0.62
.;.;.;D;P;D;D;P;.;D;D;P;.;.;.;.
Vest4
0.27, 0.30
MVP
MPC
1.8
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at